Mangrove Partners Catalyst Biosciences, Inc. Transaction History

Mangrove Partners

  • $769 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$3.5 - $8.51 $2.39 Million - $5.81 Million
-682,625 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$4.52 - $7.91 $131,586 - $230,275
-29,112 Reduced 4.09%
682,625 $4.65 Million
Q2 2019

Aug 14, 2019
BUY
$7.08 - $10.6 $5.04 Million - $7.54 Million
711,737 New
711,737 $5.25 Million

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email